πŸ‡ΊπŸ‡Έ FDA
Patent

US 11135222

Aurora kinase inhibitors

granted A61KA61K31/506A61P

Quick answer

US patent 11135222 (Aurora kinase inhibitors) held by The Regents of the University of California expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/506, A61P, A61P35/00